Dopamine carries cue persistence, ventral pallidum carries value, and μ-opioid receptors specify the entry point

Question: How do mesolimbic dopamine and ventral pallidum circuits encode incentive salience for opioid versus non-drug rewards in rodent choice paradigms?

Answer

Across these papers, the evidence does not support a single incentive-salience code that opioids and non-drug rewards express at different gains. It supports a division of labour: phasic accumbal dopamine encodes whether a cue retains motivational pull, largely independent of the current value of the outcome it predicts [23], whereas unconditioned, state-dependent reward value is carried by a non-dopaminergic VTA→ventral pallidum GABA projection and by pallidal populations tuned to palatability and physiological state [19] [1]. Opioids are not distinguished from food at the level of that value signal; they are distinguished by where they enter the circuit — through μ-opioid receptors on molecularly defined striatal populations that gate dopamine release and withdrawal affect [9] [20]. The pallidal population most specifically tied to opioid seeking is the parvalbumin/perineuronal-net one [10]. Incentive salience in this literature is therefore a composite of cue-persistence, consummatory value, and drug-specific μOR gating, and most rodent paradigms measure one component at a time.

Cue-evoked accumbal dopamine indexes incentive-salience persistence rather than reward identity

In sign-tracking rats, cue-evoked accumbal dopamine remained unchanged during an omission task in which cue interaction cancelled reward, mirroring persistent incentive salience while outcome-related dopamine tracked reward gain and loss [23]. Cue-evoked dopamine was markedly higher in sign-trackers than goal-trackers at every age measured, identifying the cue signal rather than reward-evoked release as the phenotype-differentiating variable [24]. Individual differences in D2 receptor sensitivity predict sign-tracking, and rats high on both D1 and D2 sensitivity show the strongest sign-tracking and the largest cocaine-induced ultrasonic vocalisation response [25]. Cue-evoked nucleus accumbens core dopamine scaled with reward probability and biased animals toward checking a predicted location rather than seeking, and inhibiting it increased instrumental seeking [6]. Notably, this machinery is engaged uniformly by non-drug and drug reinforcers unless additional plasticity is recruited: drugs and high-fat reward, but not sucrose, increased accumbal cholinergic interneuron pacemaker firing, and HCN blockade reduced cue-driven seeking for drug and high-fat reward while sparing sucrose seeking [22].

Dopamine's drug-related variance tracks individual vulnerability and withdrawal, not reward class

Monitoring accumbal medial shell dopamine during cocaine and fentanyl self-administration revealed a shared negative relation between intake and drug-evoked dopamine, but the dopamine signature of punishment-resistant taking diverged by drug: lower sustained post-shock cue dopamine for cocaine versus larger phasic dopamine at footshock-infusion coincidence for fentanyl [15]. Fentanyl place preference required D1 receptors in prefrontal cortex and D2 receptors in accumbens, and chemogenetic inhibition of VTA→accumbens but not VTA→prefrontal projections reduced fentanyl context seeking [17]. Accumbal core dopamine rose before oxycodone-reinforced lever presses, yet chronic oxytocin reduced motivation to self-administer oxycodone independently of oxycodone-evoked dopamine release [5]. Dopamine dips on unrewarded actions rather than peaks on rewarded ones were exaggerated by estradiol manipulation and were sufficient to accelerate punishment-resistant reward seeking when optogenetically mimicked [3]. Together these papers make opioid-related dopamine signals better predictors of escalation and punishment resistance than of opioid incentive value.

Ventral pallidum is functionally subdivided, and only the parvalbumin/perineuronal-net population is opioid-selective

Heroin increased perineuronal net density in ventral pallidum; chondroitinase ABC prevented cue-induced reinstatement, reduced excitability of pallidal parvalbumin neurons and potentiated inhibitory input onto them, and the suppression of seeking was rescued by chemogenetic activation and mimicked by inhibition of those neurons [10]. Pallidal GABAergic neurons are not simply reward-promoting: their inhibition increased both active and passive defensive responses to learned threats, indicating they also suppress competing defensive motivation [26]. Pallidal cholinergic neurons responded to cues, actions and reward retrieval in a training-independent manner, with retrieval responses reduced by reward dilution and enhanced by pre-feeding, whereas non-cholinergic pallidal neurons were modulated by pre-feeding but not by dilution [1]. Most pallidal cholinergic neurons are instead cortically projecting, bursting basal-forebrain-type cells responding to rewards, punishments and reward-predicting cues [27]. Downstream of accumbens, only shell D1-pathway terminals in pallidum were required for outcome-specific Pavlovian-instrumental transfer, not D2-pathway terminals [18].

The VTA→pallidum GABA projection supplies the unconditioned value signal that dopamine loses to the cue

VTA→ventral pallidum GABA activity reflected unconditioned reward value across extended cue-reward training, unlike dopamine, which shifted toward the cue; it tracked thirst state and, when optogenetically activated at consumption, biased two-option choice toward the stimulation-paired option even when that reward was less valuable [19]. μ-Opioid agonism in the anteromedial olfactory tubercle enhanced sucrose liking reactions and recruited Fos in caudal ventral pallidum, linking opioid hedonic amplification to a pallidal target [21]. Accumbal dopamine transients during food approach diminished across progressive ingestion and were decoupled from meal patterning by GLP-1 agonism [4]. VTA GABA neurons, unlike dopamine neurons, scaled with escalating cost in a motivational-conflict task and predicted reward-seeking motivation [13].

μ-Opioid receptor-defined striatal populations are the opioid-specific entry point, and sex gates the direction of the shift

Rare Chst9-expressing accumbal medium spiny neurons carry exceptionally high μOR, are silenced by opioids, and deletion of Oprm1 from this population abolishes fentanyl place preference [9]. In contrast, μOR on accumbal inhibitory interneurons is required for typical social behaviour, independent of exogenous opioid sensitivity [12]. μOR on Tshz1 accumbal neurons is required for withdrawal aversion; deleting it prevented withdrawal-induced dopamine decreases and affective aversion without altering physical signs [20]. oprm1 mRNA is present in both GABAergic and non-GABAergic VTA afferents, with many GABAergic afferents exceeding cortical ones [14]. Direction of effect is sex-dependent: VTA→shell activation increased sucrose responding in males but decreased cocaine responding in females [11], central amygdala optoactivation outcompeted fentanyl in males but not females except under discrete-trial choice [16], and chronic fentanyl biased reward-guided habitual choice only in females while producing perseveration in both sexes [2].

Conflicts and gaps

Two accounts of the same accumbal dopamine signal are in direct opposition: cue-evoked dopamine was unchanged when reward was omitted, contradicting value-updating accounts [23], whereas a temporal-difference actor-critic model claims to unify cocaine and fentanyl dopamine dynamics as prediction errors [15]. No retrieved study measured dopamine and ventral pallidum simultaneously inside a single opioid-versus-non-drug choice; opioid work uses self-administration or place conditioning without a competing natural-reward option, and the choice studies that exist pair food with methamphetamine or cocaine rather than an opioid [7] [11]. Whether pallidal parvalbumin/perineuronal-net dependence reflects opioid incentive specifically or cue-driven relapse generally has not been tested against a natural-reward comparator [10]. The identity of pallidal cholinergic neurons is contested between a value-coding pallidal population and a basal-forebrain-type population [1] [27]. Whether opioid reinforcement requires accumbal dopamine at all remains unresolved, given dissociations between μOR-gated behaviour and dopamine release [12] [5].

What would change the answer

A within-session discrete-trial choice between intravenous fentanyl or oxycodone and a food reinforcer equated by behavioural-economic demand curves, combined with simultaneous dual-colour photometry of accumbal dopamine and pallidal subpopulations (parvalbumin, GAD1, Slc17a7, cholinergic), would directly test whether the value and cue-persistence channels diverge by reward class. Closed-loop inhibition time-locked to choice versus consumption epochs, as already used to bias two-option choice and to constrain seeking, would establish necessity rather than correlation [19] [6]. Spatially resolved two-photon dopamine imaging through microprisms, which revealed graded anterior-posterior differences in accumbal core dynamics, should be repeated across pallidum-projecting and non-projecting accumbal subregions during drug versus food choice [8]. Finally, the design logic that identified drug-selective cellular adaptation by sparing sucrose should be inverted: cell-type-specific Oprm1 deletion combined with an explicit opioid-versus-food choice curve would show whether Chst9 and Tshz1 populations gate opioid value specifically or motivational salience generally [22] [9].

References

[1] Gannon, A., Setara, R., Maysonet, C., Salazar, R. E., Zuelke, D. R., Bowen, J. E., Gallo, E. F.. "Ventral Pallidum Cholinergic Neurons Respond to Reward and Signal Reward Value". bioRxiv. 2026-05-24T00:00:00.000Z. URL: https://doi.org/10.64898/2026.05.24.726981

[2] Garr, E., Cheng, Y., Dong, A., Janak, P. H.. "Fentanyl reinforcement history has sex-specific effects on multi-step decision-making". bioRxiv. 2025-06-05T00:00:00.000Z. URL: https://doi.org/10.1101/2024.10.10.617707

[3] Mwenda, N., Nadel, J. A., Shen, T., Seiler, J. L., Lerner, T. N.. "Dopamine dips during unrewarded actions promote punishment-resistant reward seeking". bioRxiv. 2026-08-03T00:00:00.000Z. URL: https://doi.org/10.64898/2026.08.01.742224

[4] Mourra, D., Murphy, C. E., Hourany, E., Centeno, K., Gnazzo, F., Beeler, J. A.. "Striatal signaling tracks naturalistic short-term fluctuations in hunger-satiety". bioRxiv. 2026-06-29T00:00:00.000Z. URL: https://doi.org/10.1101/2025.04.29.651295

[5] Blount, H. L., Gits, M., Colley, E. A., Kang, J., Wilkinson, C. S., Schwendt, M., Knackstedt, L. A.. "Oxytocin modulates behavioral economic and dopaminergic measures of motivation to seek intravenous oxycodone in rats". bioRxiv. 2026-10-19T00:00:00.000Z. URL: https://doi.org/10.64898/2026.10.16.759686

[6] Malvaez, M., Suarez, A., Griffin, N. K., Ramirez-Armenta, K., Ostlund, S. B., Wassum, K. M.. "Dopamine supports reward prediction to shape reward-pursuit strategy". bioRxiv. 2025-12-11T00:00:00.000Z. URL: https://doi.org/10.1101/2025.08.22.671841

[7] Baldwin, A., Banks, M.. "Effects of nonpharmacological manipulations and repeated xanomeline treatment on methamphetamine-vs-food choice in Sprague Dawley and Long Evans rats". bioRxiv. 2025-12-24T00:00:00.000Z. URL: https://doi.org/10.64898/2025.12.22.696048

[8] Kang, S., Burke, D. A., Kornbrek, C., Farouq, F., Jeong, H., Namboodiri, V. M. K., Berke, J.. "Divergent Dopamine Dynamics within the Accumbens Core". bioRxiv. 2026-09-29T00:00:00.000Z. URL: https://doi.org/10.64898/2026.09.23.753606

[9] Drake, O. R., Fiore, C. M., Jorgensen, E. T., Newman, C. E., Potter, L. A., Trull, A., Pradeep, A., Ianov, L., Peters, J., Heinsbroek, J. A., Day, J. J.. "A conserved population of genetically defined striatal neurons gates opioid reward". bioRxiv. 2026-07-30T00:00:00.000Z. URL: https://doi.org/10.64898/2026.07.28.741269

[10] Nogueira, M., Giannotti, G., Miller, C. N., Guaderrama, S. D., Kregar, N. P., Wiedmeyer, B., Fayette, N., Heinsbroek, J. A.. "Ventral pallidal perineuronal nets regulate opioid relapse". bioRxiv. 2026-01-22T00:00:00.000Z. URL: https://doi.org/10.64898/2026.01.21.700926

[11] McLaurin, K. A., Illenberger, J. M., Li, H., Booze, R., Mactutus, C. F.. "SEX-DEPENDENT MODULATION OF BEHAVIORAL ALLOCATION VIA VENTRAL TEGMENTAL AREA-NUCLEUS ACCUMBENS SHELL CIRCUITRY". bioRxiv. 2025-02-10T00:00:00.000Z. URL: https://doi.org/10.1101/2025.02.09.637318

[12] Toddes, C., Lefevre, E. M., Retzlaff, C. L., Zugschwert, L., Khan, S., Myhre, E., Gauthier, E. A., Fernandez de Velasco, E. M., Kieffer, B. L., Rothwell, P. E.. "Mu opioid receptor expression by nucleus accumbens inhibitory interneurons promotes affiliative social behavior". bioRxiv. 2024-10-29T00:00:00.000Z. URL: https://doi.org/10.1101/2024.10.28.620729

[13] Stelzner, M. E., Wolff, A. R., Saunders, B. T.. "Ventral tegmental area GABA neurons integrate positive and negative valence". bioRxiv. 2025-08-20T00:00:00.000Z. URL: https://doi.org/10.1101/2024.12.07.627330

[14] Hohmeister, M., Culver, O. P., Jhou, T.. "Mu-opioid receptor expression across cell-type specific afferents to the ventral tegmental area in male mice.". bioRxiv. 2026-05-23T00:00:00.000Z. URL: https://doi.org/10.64898/2026.05.21.726769

[15] Chen, K., Zheng, H., Sevrain, G., Xiao, W., Wang, C., Sundai, A., Fiete, I., Wang, F.. "Dopamine signatures of excessive and compulsive cocaine and fentanyl use". bioRxiv. 2026-01-20T00:00:00.000Z. URL: https://doi.org/10.64898/2026.01.18.700215

[16] Chaloux-Pinette, E., Vela Mirelez-Prince, M., Soto, S., Ananth, K., Tong, X., Silva, V., Rodriguez, D., Janak, P. H.. "Optogenetic Central Amygdala Stimulation is Highly Reinforcing and Strongly Outcompetes Fentanyl Self-Administration in Male, but not Female, Rats". bioRxiv. 2024-11-10T00:00:00.000Z. URL: https://doi.org/10.1101/2024.11.10.622812

[17] Montemarano, A., Sohail, H., Murdaugh, L. B., Derr, K., Alkhaleel, F. A., Fox, L. D., Pandey, S., Fox, M. E.. "Mesolimbic and mesocortical pathways differentially support fentanyl-context associations". bioRxiv. 2026-07-03T00:00:00.000Z. URL: https://doi.org/10.1101/2025.11.26.690827

[18] Soegyono, O., Pepin, E., Leung, B. K., Chieng, B., Balleine, B. W., Laurent, V.. "The influence of nucleus accumbens shell D1 and D2 neurons on outcome-specific Pavlovian instrumental transfer". bioRxiv. 2025-10-08T00:00:00.000Z. URL: https://doi.org/10.1101/2025.05.26.656228

[19] Zhou, W., Yousuf, H., Mineur, Y. S., Picciotto, M.. "A ventral tegmental area GABAergic projection to the ventral pallidum regulates value-based decision making in mice". bioRxiv. 2026-02-20T00:00:00.000Z. URL: https://doi.org/10.64898/2026.02.19.706858

[20] Pomrenze, M. B., Tucciarone, J. M., Touponse, G. C., Denomme, N., Phan, B. N., St. Laurent, R., Galiza Soares, J. A., Cardozo Pinto, D. F., Guo, M. Y., Baek, J., Chen, A. P. F., Zhang, Z., Shank, A., Freyberg, Z., Pfenning, A. R., Eshel, N., Malenka, R. C.. "Local control of dopamine release in nucleus accumbens gates opioid withdrawal aversion". bioRxiv. 2026-05-28T00:00:00.000Z. URL: https://doi.org/10.64898/2026.05.25.727738

[21] Murata, K., Berridge, K. C.. "Hedonic hotspot in rat olfactory tubercle: map for mu-opioid, orexin, and muscimol enhancement of sucrose 'liking'.". bioRxiv. 2025-11-19T00:00:00.000Z. URL: https://doi.org/10.1101/2025.11.18.689156

[22] Huang, S., Zhang, J., Li, Y., Lv, X., Song, Z., Ding, Z., Li, Z., Tian, Y., Zang, X., Hu, Y., Luo, Y., Li, H., Shi, J., Lu, L., Huang, Z., Xue, Y.-X.. "An accumbal cholinergic ISR-HCN2 axis sustains maladaptive cue motivation". bioRxiv. 2026-09-24T00:00:00.000Z. URL: https://doi.org/10.64898/2026.09.18.752826

[23] Townsend, E. S., Garrod, D., Smith, K. S.. "Phasic dopamine encodes persistent attraction to reward cues". bioRxiv. 2025-12-12T00:00:00.000Z. URL: https://doi.org/10.64898/2025.12.09.693300

[24] Herring, E. W., Hafenbreidel, M., Patel, E. D., Kupelian, P., Syamala, T., Zeng, S., Torregrossa, M. M., Morrison, S. E.. "A distinct adolescent profile for activity and dopamine release in the nucleus accumbens during Pavlovian conditioning". bioRxiv. 2026-05-26T00:00:00.000Z. URL: https://doi.org/10.64898/2026.05.21.726881

[25] Amissah, N. K., Tripi, J. A., King, C. P., Meyer, P. J.. "Dopamine receptor sensitivity and Pavlovian conditioned approach". bioRxiv. 2025-09-28T00:00:00.000Z. URL: https://doi.org/10.1101/2025.09.26.678801

[26] Ramirez, E. M., Martinez, M. X., Rokerya, R. K., Vera, V. A., Ruiz, C. M., Farrell, M. R., Walawalkar, S. A., Ramirez-Ramirez, H., Kollman, G. J., Mahler, S. V.. "Ventral Pallidum GABA Neuron Inhibition Augments Context-Appropriate Defensive Responses to Learned Threat Cues". bioRxiv. 2025-12-22T00:00:00.000Z. URL: https://doi.org/10.1101/2025.08.28.672918

[27] Schlingloff, D., Szabo, I., Gulyas, E., Kiraly, B., Kispal, R., Stephenson-Jones, M., Hangya, B.. "Most ventral pallidal cholinergic neurons are cortically projecting bursting basal forebrain cholinergic neurons". bioRxiv. 2025-02-26T00:00:00.000Z. URL: https://doi.org/10.1101/2025.02.23.639747

How this survey was made

This survey answers one question: “How do mesolimbic dopamine and ventral pallidum circuits encode incentive salience for opioid versus non-drug rewards in rodent choice paradigms?”

We keep our own collection of recent preprints and refresh it every day from bioRxiv, medRxiv, arXiv, PsyArXiv, SocArXiv and ChemRxiv. For each survey, we search that collection for recent work and keep the strongest matches: papers that use the same terms as the question, and papers on the same topic in different words.

The text was written from the titles and abstracts of those papers; the full texts were not read. Statements that draw on a particular paper are marked with a number in brackets. The reference list just above is the 27 papers whose work this text draws on, chosen from the 130 papers those searches returned; the rest of the shortlist is not printed. It is not a complete review of everything published on the question.

Treat this as a starting point and a reading list, not a peer-reviewed review. The searches behind this survey ran on October 21, 2026 and covered work from the previous two years.